pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
dbffdd1f-5f07-45c8-a551-f29672e91f60
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-17 17:09:30
Income (reported)
$30,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

VAN SCOYOC ASSOCIATES

Government Relations Consultant

Contact
H. STEWART VAN SCOYOC
Phone
+1 202-638-1950
Address
zip:20024, city:Washington, state:DC, street:800 Maine Avenue, SW Suite 800

Client

ARUP LABORATORIES, INC.

Diagnostic testing laboratory

State
UT
Country
US
Government-entity client
false
Effective date
2020-02-01

Issues lobbied + lobbyists

BUD — Budget/Appropriations

Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Diagnostic Lab Testing related issues Monitor President's Budget FY2027

Lobbyists: MATT HENKEN

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Possible Health policy package Health workforce visa related issues Monitor the following: H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2026, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives

Lobbyists: MATT HENKEN

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MED — Medical/Disease Research/Clinical Labs

FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Possible Health policy package Health workforce visa related issues Monitor the following: H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2026, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives

Lobbyists: MATT HENKEN

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.